Keeling Curve

Primary Project Category:

Secondary Project Category:

How Project Affects Greenhouse Gas (GHG) Emissions:

['Removes/stores GHGs (e.g., projects that capture, sequester, or otherwise enhance the "sinks" that accumulate and store GHGs)']

Impact on Underrepresented Groups:

Terra Bioware is committed to empowering underrepresented groups in the climate movement by promoting diversity, equity, and inclusion within our organization and through our outreach efforts.

Workforce Diversity: Our team is diverse, with individuals from various backgrounds, including women and people of color in key leadership and scientific roles. Shruti Singh, the founder and CEO, leads with a focus on creating equal opportunities for underrepresented groups in the business and climate space. Additionally, Dr. Akila Thirumalai and Praveen Kumar hold leadership roles in biomanufacturing and operations, bringing expertise and mentorship to younger professionals and students, especially women and minorities, in STEM fields.

Community Engagement: Terra Bioware actively collaborates with local universities and research institutions in regions with high levels of youth unemployment and underrepresentation in scientific careers, offering internships, mentorship, and training programs to foster the next generation of climate leaders from diverse backgrounds.

Climate Vulnerable Communities: Our technology has the potential to mitigate environmental and economic challenges in regions vulnerable to climate change by providing sustainable, low-cost alternatives to traditional plastic production. These communities will benefit from our scalable biopolymer production, which can create local jobs, reduce pollution, and address waste management issues.

Sub-Categories:

Mission Statement:

Terra Bioware is an early-stage deeptech startup building circular biomaterials, specialty (PHAs), from carbon emissions at scale. We are on a mission to accelerate the transition to affordable, safe, and versatile biomaterials. Our three market verticals include specialty biochemicals, medical biomaterials and consumer utilities.

Sources of Past Funding: